The FDA has approved Arena Pharmaceuticals' new weight loss drug Lorcaserin, and the stock will resume trading at 1:45 PM ET. CNBC's Seema Mody has the details.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT